Skip to main content
. Author manuscript; available in PMC: 2022 May 9.
Published in final edited form as: J Urol. 2015 Apr 6;194(4):929–938. doi: 10.1016/j.juro.2015.03.119

Table 3.

IVC level II thrombi

Median/Mean
Pt No. 1 2 3 4 5 6 7 Median/Mean
Age (yrs) 66 72 74 65 82 69 36 69/66.2
Gender M M M M M M F
BMI (kg/m2) 40.3 26.7 41.9 32.2 24 31 28 31.6/32.6
ASA class III II III III II II III
Renal tumor:
 Size (cm) 11 6.5 19.5 8.7 7.2 8.5 6.7 8.5/9.7
 Side Rt Rt Lt Rt Rt Lt Rt
IVC thrombus length (cm) 2.5 3.5 2 5.3 3 4.5 3.1 3.4/3.1
Preexisting metastasis 2.2 cm Node pericaval No No No No No No
Neoadjuvant therapy No No No No No No No
Preop renal embolization Yes No No Yes Yes Yes No
Proximal IVC control level Suprarenal IVC Suprarenal IVC Suprarenal IVC Suprarenal IVC Suprarenal IVC Suprarenal IVC Suprarenal IVC
No. hepatic veins taken 0 0 0 0 0 0 2 0/0.3
O.R. time (hrs) 4.0 4.5 6.1 5 4.5 3 3.5 4.5/4.5
Blood loss (cc) 400 300 200 280 700 100 100 280/297
Blood transfusion No Yes No No No No No
Hospital stay (days) 7 4 8 5 3 4 1 4/4.6
Tumor histology RCC RCC RCC RCC RCC RCC RCC
Tumor grade 2 3 4 3 4 3 2
TNM stage T3aN1Mx T3aN0Mx T4aNxMx T3bNxMx T3bNxMx T3aN0Mx T3bNxMx
Mos followup 39 29 24 18 8 3 1 21/20.2
Current status Alive with Mets Alive/NED Alive/NED Alive/NED Alive with Mets Alive/NED Alive/NED